Similar articles for PMID: 9429070

Year	Number of Results
1988	1
1989	1
1990	2
1991	3
1992	2
1993	3
1994	2
1995	9
1996	9
1997	16
1998	12
1999	9
2000	13
2001	6
2002	7
2003	14
2004	7
2005	6
2006	9
2007	6
2008	6
2009	8
2010	4
2011	1
2012	2
2013	4
2014	5
2015	3
2016	2
2017	2
2018	1
2020	1
2021	3
2022	2
2024	0

1

Severe anticholinergic side effects with venlafaxine-fluoxetine combination.

Benazzi F. Benazzi F. Can J Psychiatry. 1997 Nov;42(9):980-1. doi: 10.1177/070674379704200916. Can J Psychiatry. 1997. PMID: 9429070 No abstract available.

2

Venlafaxine-fluoxetine interaction.

Benazzi F. Benazzi F. J Clin Psychopharmacol. 1999 Feb;19(1):96-8. doi: 10.1097/00004714-199902000-00017. J Clin Psychopharmacol. 1999. PMID: 9934950 No abstract available.

3

Re: Severe anticholinergic side effects with venlafaxine-fluoxetine combination.

Zedkova L, Coupland NJ. Zedkova L, et al. Can J Psychiatry. 1998 Jun;43(5):523. Can J Psychiatry. 1998. PMID: 9653539 No abstract available.

4

Severe hypertriglyceridemia secondary to venlafaxine and fluoxetine.

Teitelbaum M. Teitelbaum M. Psychosomatics. 2001 Sep-Oct;42(5):440-1. doi: 10.1176/appi.psy.42.5.440. Psychosomatics. 2001. PMID: 11739916 No abstract available.

5

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group.

Clerc GE, Ruimy P, Verdeau-Pallès J. Clerc GE, et al. Int Clin Psychopharmacol. 1994 Sep;9(3):139-43. doi: 10.1097/00004850-199409000-00001. Int Clin Psychopharmacol. 1994. PMID: 7814822 Clinical Trial.

6

Venlafaxine versus fluoxetine in the treatment of atypical anorectic outpatients: a preliminary study.

Ricca V, Mannucci E, Paionni A, Di Bernardo M, Cellini M, Cabras PL, Rotella CM. Ricca V, et al. Eat Weight Disord. 1999 Mar;4(1):10-4. doi: 10.1007/BF03341582. Eat Weight Disord. 1999. PMID: 10728173 Clinical Trial.

7

Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.

Benazzi F. Benazzi F. J Psychopharmacol. 1997;11(2):190-1. doi: 10.1177/026988119701100213. J Psychopharmacol. 1997. PMID: 9208383 No abstract available.

8

Agranulocytosis during treatment with mianserin and venlafaxine.

Lucht MJ, Kleinschmidt R, Maier W, Rietschel M. Lucht MJ, et al. J Clin Psychopharmacol. 2000 Aug;20(4):490-1. doi: 10.1097/00004714-200008000-00017. J Clin Psychopharmacol. 2000. PMID: 10917414 No abstract available.

9

Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.

Entsuah R, Gorman JM. Entsuah R, et al. J Psychiatr Res. 2002 May-Jun;36(3):111-8. doi: 10.1016/s0022-3956(01)00055-3. J Psychiatr Res. 2002. PMID: 11886688 Clinical Trial.

10

Venlafaxine and ecchymosis.

Kohn S, Labbate LA. Kohn S, et al. Can J Psychiatry. 1997 Feb;42(1):91. doi: 10.1177/070674379704200126. Can J Psychiatry. 1997. PMID: 9040933 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

171 results

Results by year